{"meta":{"query_hash":"93d0b3d57dde","filters":{"venue":"Journal of Psoriasis and Psoriatic Arthritis"},"cohort_total":20,"direct_labels_cover":0,"predictions_cover":20,"exported":20,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/93d0b3d57dde","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Psoriasis+and+Psoriatic+Arthritis"},"results":[{"id":"W2790907408","doi":"10.1177/247553031700200206","title":"Greater Efficacy with Secukinumab Treatment is Associated with Greater Psoriasis Symptom Relief: Results from Secukinumab Clinical Trial Data","year":2017,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Secukinumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Itching; Clinical trial; Internal medicine; Dermatology; Severity of illness; Physical therapy; Psoriatic arthritis","score_opus":0.07019014492243286,"score_gpt":0.30813629517120944,"score_spread":0.23794615024877658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790907408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96690446,0.023468018,0.0007631163,0.0017918772,0.00023082596,0.0006524889,0.0017628975,0.00007203893,0.004354166],"genre_scores_gemma":[0.9906052,0.005336793,0.0005889373,0.0006578214,0.00032864185,0.0002731858,0.0012759294,0.000024258137,0.0009093133],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9961947,0.0026804507,0.00035815718,0.00024432558,0.0003577919,0.00016452657],"domain_scores_gemma":[0.99026275,0.005446068,0.0025100159,0.0006716625,0.0005481315,0.0005613928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008415051,0.00082805665,0.0017830213,0.00022765942,0.00027148574,0.0011946316,0.00043355688,0.0008987602,0.005799961],"category_scores_gemma":[0.006812647,0.000259074,0.0023836358,0.0005986782,0.00080044434,0.0007277452,0.00035343185,0.0017523259,0.00059260405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74446493,0.007651233,0.05970553,0.0047464925,0.021165747,0.00021273218,0.00030968865,0.002040067,0.010987394,0.00047415635,0.005150513,0.14309147],"study_design_scores_gemma":[0.31444257,0.2821636,0.33888736,0.0010400545,0.032420605,0.0012255327,0.0003064707,0.0035620816,0.007230985,0.0011548701,0.017431581,0.0001343107],"about_ca_topic_score_codex":0.00024016452,"about_ca_topic_score_gemma":0.0005885841,"teacher_disagreement_score":0.008415051,"about_ca_system_score_codex":0.00030308924,"about_ca_system_score_gemma":0.0004974614,"threshold_uncertainty_score":0.04450363},"labels":[],"label_agreement":null},{"id":"W2793685260","doi":"10.1177/247553031600100406","title":"Secukinumab Provides Clearer Skin and Better Control on Patient-Reported Psoriasis Symptoms of Itching, Pain, and Scaling than Placebo and Etanercept","year":2016,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Secukinumab; Medicine; Etanercept; Itching; Placebo; Psoriasis; Dermatology; Erythema; Internal medicine; Psoriatic arthritis; Tumor necrosis factor alpha; Pathology","score_opus":0.007232418702490851,"score_gpt":0.20826899331836302,"score_spread":0.20103657461587215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793685260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772456,0.01387221,0.0013182954,0.00055126025,0.00023097241,0.00009470974,0.00026717945,0.00021590474,0.006203788],"genre_scores_gemma":[0.9932789,0.0023433343,0.001197682,0.00025313295,0.0002060763,0.00005426879,0.00019742576,0.000020649404,0.0024485497],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996264,0.00014770644,0.000040206844,0.000052499014,0.00008339176,0.0000497747],"domain_scores_gemma":[0.9996797,0.00009749,0.00010428355,0.000032496373,0.000023747096,0.00006234352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046739663,0.00036731877,0.0008603168,0.0002616175,0.00011930777,0.00035194805,0.00009327205,0.00024482826,0.011207774],"category_scores_gemma":[0.0005940738,0.00010722905,0.00032536482,0.00019010348,0.00014935597,0.0004047627,0.00013445668,0.0005397581,0.00074862945],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0401223,0.004825414,0.009296688,0.0018693798,0.000426095,0.00018951467,0.0001208595,0.0007070522,0.38664633,0.0004688619,0.0030119934,0.5523156],"study_design_scores_gemma":[0.023703469,0.19930287,0.47155082,0.00064347737,0.0011779935,0.0076131476,0.0004367743,0.0036989506,0.24528433,0.0009178248,0.045544907,0.0001254095],"about_ca_topic_score_codex":0.000119635755,"about_ca_topic_score_gemma":0.00024778934,"teacher_disagreement_score":0.011207774,"about_ca_system_score_codex":0.00011027207,"about_ca_system_score_gemma":0.000112746835,"threshold_uncertainty_score":0.037493765},"labels":[],"label_agreement":null},{"id":"W2897757466","doi":"10.1177/2475530318806255","title":"Eight-Patient Case Series of Palmoplantar Pustulosis Treated Successfully With Apremilast","year":2018,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University; Trent University; SKiN Health","funders":"","keywords":"Apremilast; Medicine; Psoriatic arthritis; Dermatology; Psoriasis; Population; Ustekinumab; Palmoplantar pustulosis; Internal medicine; Adalimumab; Disease","score_opus":0.009125517270176981,"score_gpt":0.20653983874739915,"score_spread":0.19741432147722215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897757466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790754,0.0037570249,0.0034309889,0.001177697,0.000281945,0.00029847992,0.0002177271,0.00017951945,0.011581152],"genre_scores_gemma":[0.996689,0.00083019515,0.000814223,0.00042245668,0.0002004699,0.000051952702,0.00007782322,0.000021252932,0.0008925954],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992887,0.000100695695,0.0001127377,0.00015476425,0.00013390959,0.0002092603],"domain_scores_gemma":[0.9980781,0.00048687615,0.00060335424,0.00020903429,0.00013286597,0.00048970035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038959362,0.0012662092,0.001051411,0.0018838439,0.0026226481,0.0012018587,0.0008339158,0.002262755,0.0026019043],"category_scores_gemma":[0.0035461984,0.0008699441,0.0010814953,0.0012033468,0.0012483608,0.0011812302,0.0010738167,0.0019492937,0.0010490943],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049265564,0.00017629894,0.039596476,0.00004578006,0.000031227122,0.95577157,0.00037734045,0.00009903339,0.0006680895,0.00016359627,0.0003129565,0.0027084386],"study_design_scores_gemma":[0.000013468867,0.00012931314,0.0071604177,0.000016851393,0.000019667183,0.9915371,0.00018181358,0.000116985575,0.00027156624,0.000067494795,0.0004757031,0.000009632247],"about_ca_topic_score_codex":0.0008432271,"about_ca_topic_score_gemma":0.0012560047,"teacher_disagreement_score":0.0026226481,"about_ca_system_score_codex":0.0006965117,"about_ca_system_score_gemma":0.0007946512,"threshold_uncertainty_score":0.0087041855},"labels":[],"label_agreement":null},{"id":"W2908033840","doi":"10.1177/2475530318818816","title":"Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis During Induction Phase: A Systematic Review and Network Meta-Analysis","year":2018,"lang":"en","type":"review","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Janssen Research and Development","keywords":"Medicine; Ixekizumab; Psoriasis Area and Severity Index; Meta-analysis; Randomized controlled trial; Internal medicine; Relative risk; Psoriasis; Confidence interval; Dermatology; Secukinumab; Psoriatic arthritis","score_opus":0.07589645418014619,"score_gpt":0.3256763874813887,"score_spread":0.24977993330124254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908033840","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033414278,0.99395096,0.0008812108,0.0002546616,0.000107937,0.0004300387,0.0006790814,0.000030467681,0.00032430314],"genre_scores_gemma":[0.13152894,0.86046225,0.0036094573,0.0008699007,0.0001904803,0.0016958732,0.0012720415,0.000035673987,0.00033544376],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9896769,0.0054559293,0.002327542,0.0009963138,0.0012668587,0.0002764999],"domain_scores_gemma":[0.9815068,0.013091798,0.0031606934,0.00045285054,0.0015443425,0.00024354363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015678661,0.0026707228,0.016879886,0.008744835,0.0005921019,0.0028076745,0.0023014697,0.0016955046,0.0042217257],"category_scores_gemma":[0.03146042,0.0011577179,0.03354885,0.008459102,0.0005411145,0.0017857542,0.0015586844,0.0017409605,0.00035545573],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019287693,0.0000437003,0.0030272682,0.4563521,0.51460475,0.00011746325,0.00008346925,0.0010532471,0.00022234685,0.00021599297,0.00093856174,0.021412363],"study_design_scores_gemma":[0.00060241483,0.00017712143,0.0026773019,0.034406908,0.9593244,0.00008739512,0.00002962329,0.0003630946,0.00008045459,0.00030985,0.0019180063,0.000023375738],"about_ca_topic_score_codex":0.0082086455,"about_ca_topic_score_gemma":0.01652534,"teacher_disagreement_score":0.016879886,"about_ca_system_score_codex":0.0032100314,"about_ca_system_score_gemma":0.004974109,"threshold_uncertainty_score":0.08291769},"labels":[],"label_agreement":null},{"id":"W2968760378","doi":"10.1177/2475530319867095","title":"Ixekizumab—An Effective and Safe Treatment for Moderate-to-Severe Plaque Psoriasis in Patients Previously Treated With Other IL-17 Inhibitors: Results From IXORA-P","year":2019,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Secukinumab; Plaque psoriasis; Psoriasis; Internal medicine; Dermatology","score_opus":0.008997813675163136,"score_gpt":0.2217314020076513,"score_spread":0.21273358833248815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968760378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701487,0.025108429,0.0006223768,0.0007573086,0.00017896593,0.0005491068,0.0003615444,0.00004082326,0.0022327679],"genre_scores_gemma":[0.9870461,0.009395439,0.0010507139,0.00061198627,0.00033641208,0.00026168345,0.00052497484,0.000012682789,0.0007599459],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99962664,0.00019154346,0.00003070836,0.000049859515,0.0000545185,0.000046670404],"domain_scores_gemma":[0.9995189,0.0001590878,0.00012403601,0.000043533182,0.000030651274,0.00012390419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014342585,0.00035573437,0.0008796728,0.00016442234,0.00021011055,0.00047079322,0.00030693875,0.00034603337,0.002639862],"category_scores_gemma":[0.0008051697,0.00015497528,0.001168542,0.00018666897,0.00038379946,0.00033371977,0.00020455975,0.0013040917,0.00028492158],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37006345,0.01580807,0.01452725,0.0023688592,0.0029112718,0.00034971596,0.0001993239,0.0009959232,0.031539973,0.0003921772,0.004450127,0.55639386],"study_design_scores_gemma":[0.5078331,0.38328803,0.08004035,0.0004883063,0.002541605,0.001917166,0.00012008519,0.0014065355,0.008103173,0.0005035282,0.013715881,0.000042213367],"about_ca_topic_score_codex":0.0003261297,"about_ca_topic_score_gemma":0.0007252811,"teacher_disagreement_score":0.002639862,"about_ca_system_score_codex":0.0002837083,"about_ca_system_score_gemma":0.0004944927,"threshold_uncertainty_score":0.008831203},"labels":[],"label_agreement":null},{"id":"W2995141132","doi":"10.1177/2475530319890832","title":"Evidence for Psoriatic Arthritis Impact of Disease (PsAID12) as Core Instrument to Measure Health-Related Quality of Life in Psoriatic Arthritis: A Systematic Review of Psychometric Properties","year":2019,"lang":"en","type":"review","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Ottawa Hospital; University of Ottawa; Toronto Western Hospital; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Psoriatic arthritis; Medicine; Quality of life (healthcare); Arthritis; Measure (data warehouse); Psoriasis; Dermatology; Internal medicine; Computer science; Nursing; Data mining","score_opus":0.2138143789498651,"score_gpt":0.4094264589114672,"score_spread":0.19561207996160207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995141132","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013627168,0.99638915,0.0003129143,0.0006376053,0.0001469083,0.0003300602,0.00047256312,0.000009407859,0.00033873846],"genre_scores_gemma":[0.026060289,0.9695338,0.0015822311,0.0012393637,0.00014593772,0.0008644821,0.0004736601,0.000010644066,0.00008962172],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97598016,0.007290117,0.009205997,0.0016501375,0.005487689,0.00038595436],"domain_scores_gemma":[0.8859241,0.081376314,0.021346832,0.0017184381,0.008763023,0.000871333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028043643,0.001521646,0.008137773,0.017098047,0.00083491206,0.003689945,0.0021406056,0.0026669914,0.0049149534],"category_scores_gemma":[0.11088821,0.0012432063,0.00966456,0.014135007,0.0017422779,0.003362997,0.0024675122,0.0017991139,0.00051068],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025380705,0.00002727902,0.002410423,0.90995413,0.010767373,0.00006676108,0.00020425286,0.0000993015,0.00017391794,0.00035499834,0.0015796351,0.07410809],"study_design_scores_gemma":[0.0002769381,0.00018758523,0.009637506,0.91549236,0.059323598,0.00028323065,0.00022121733,0.00010506855,0.00015823054,0.00052857364,0.013745263,0.000040542745],"about_ca_topic_score_codex":0.00595224,"about_ca_topic_score_gemma":0.013834689,"teacher_disagreement_score":0.028043643,"about_ca_system_score_codex":0.0038473469,"about_ca_system_score_gemma":0.014807366,"threshold_uncertainty_score":0.14831072},"labels":[],"label_agreement":null},{"id":"W3012975988","doi":"10.1177/2475530320913879","title":"Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2018 Annual Meeting Summary","year":2020,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Krembil Foundation; University of Toronto; Memorial University of Newfoundland","funders":"","keywords":"Psoriatic arthritis; Medicine; Psoriasis; Family medicine; Delphi method; Alternative medicine; Dermatology; Pathology","score_opus":0.016533932133536877,"score_gpt":0.2682940204100344,"score_spread":0.25176008827649754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012975988","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.068638615,0.012745877,0.011474002,0.44192985,0.07886169,0.00752623,0.029188659,0.0011989553,0.34843618],"genre_scores_gemma":[0.30563012,0.03187017,0.020909918,0.04640865,0.055197015,0.017048659,0.05760532,0.0009748967,0.46435517],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974872,0.00084853574,0.00022125362,0.00013592615,0.00090195617,0.00040508521],"domain_scores_gemma":[0.9936278,0.0005758246,0.0003723839,0.00013411177,0.003405712,0.0018842113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008802684,0.0004017774,0.00026441726,0.0010800266,0.0009525738,0.00205412,0.00066083943,0.0008462742,0.03905615],"category_scores_gemma":[0.008767527,0.00015953256,0.0002772649,0.00059693016,0.00023027409,0.00088033156,0.0013572618,0.0013674905,0.008910061],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011863935,0.0000742339,0.0018294267,0.00020159305,0.000005334081,0.0000966427,0.00023787969,0.000066822904,0.0003726807,0.00066655513,0.9434603,0.05286991],"study_design_scores_gemma":[0.000031411284,0.000086052765,0.0072824256,0.00046690422,0.000004817701,0.00010113283,0.0006433635,0.00015068646,0.00028968512,0.0004700502,0.99045956,0.000013880544],"about_ca_topic_score_codex":0.002572994,"about_ca_topic_score_gemma":0.004952105,"teacher_disagreement_score":0.03905615,"about_ca_system_score_codex":0.0024306192,"about_ca_system_score_gemma":0.0052285367,"threshold_uncertainty_score":0.13065583},"labels":[],"label_agreement":null},{"id":"W3091198135","doi":"10.1177/2475530320963196","title":"Patient–Physician Alignment in Satisfaction With Psoriatic Arthritis Treatment: Analysis From a Cross-Sectional Survey in the United States and Europe","year":2020,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Patient Satisfaction in Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Psoriatic arthritis; Cross-sectional study; Patient satisfaction; Multivariate analysis; Family medicine; Disease; Disease control; Bivariate analysis; Quality of life (healthcare); Multivariate statistics; Physical therapy; Internal medicine; Surgery; Environmental health; Nursing; Pathology","score_opus":0.06038698771814206,"score_gpt":0.3486366828956847,"score_spread":0.2882496951775427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091198135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99932945,0.00008096419,0.000061057544,0.000052982592,0.0000023740847,0.000007728903,0.00023749408,0.0000016916957,0.0002263478],"genre_scores_gemma":[0.99961984,0.000035350124,0.000039386676,0.000035223326,0.0000032763198,0.000006700439,0.00023310976,7.743727e-7,0.000026335854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724615,0.0014643539,0.00039400937,0.00021881229,0.00045187873,0.0002249198],"domain_scores_gemma":[0.99131197,0.002651674,0.0040407,0.00033693865,0.00064722705,0.0010114779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033876335,0.00016373864,0.00040231875,0.0011760903,0.00034164207,0.00071377767,0.00028759646,0.000520964,0.0015066757],"category_scores_gemma":[0.007348942,0.0002461406,0.00073204,0.0018406222,0.00042250185,0.000484518,0.0007757181,0.00048823393,0.000199368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039719256,0.000023794139,0.9992538,0.000004224821,0.000040365063,0.000011846083,0.00008237347,0.00002574419,0.000020348789,0.0000050958843,0.00004718533,0.0004453985],"study_design_scores_gemma":[0.0000043499726,0.000053146818,0.9994449,0.0000033615297,0.000008790807,0.00004918522,0.00021658366,0.00014515647,0.000013320428,0.0000035789988,0.000055775363,0.0000018181349],"about_ca_topic_score_codex":0.005527739,"about_ca_topic_score_gemma":0.0044631287,"teacher_disagreement_score":0.005527739,"about_ca_system_score_codex":0.0004190187,"about_ca_system_score_gemma":0.00039389217,"threshold_uncertainty_score":0.017915726},"labels":[],"label_agreement":null},{"id":"W3095186834","doi":"10.1177/2475530320970531","title":"A Description of Treatment Patterns of Psoriasis by Medical Providers and Disease Severity in US Women","year":2020,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"National Cancer Institute","keywords":"Psoriasis; Medicine; Dermatology; Disease; Severity of illness; Internal medicine","score_opus":0.01474809790695775,"score_gpt":0.22402350219118466,"score_spread":0.20927540428422692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095186834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540627,0.00056204794,0.000107294654,0.00020471285,0.000006402083,0.000025937761,0.0022819624,0.000008698308,0.0013966815],"genre_scores_gemma":[0.9980868,0.00029914582,0.00019596472,0.00005751482,0.000010337271,0.00003722403,0.0011545976,0.0000031712925,0.00015525949],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993932,0.00018326637,0.00013878124,0.00007280043,0.0001275866,0.000084316714],"domain_scores_gemma":[0.99698156,0.0006765767,0.0017580523,0.000062015424,0.00032638764,0.00019539223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006688913,0.00014147947,0.00019061877,0.0020592,0.00028371505,0.0003255528,0.00024136069,0.00024657985,0.0018401081],"category_scores_gemma":[0.0030219564,0.00012952593,0.00041225032,0.0021077474,0.0001869675,0.0004018381,0.00035638525,0.00023951894,0.00022494163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004962995,0.000010947773,0.99718046,0.0000179875,0.000016077718,0.000027900476,0.00020655396,0.000025032878,0.00009113297,0.000012007334,0.00025054696,0.0021117204],"study_design_scores_gemma":[0.0000034183747,0.000043598953,0.9985442,0.000015485579,0.000008743022,0.00021859912,0.0006650215,0.00009161582,0.000033534772,0.000013378718,0.0003594652,0.0000029027917],"about_ca_topic_score_codex":0.008327505,"about_ca_topic_score_gemma":0.009368486,"teacher_disagreement_score":0.008327505,"about_ca_system_score_codex":0.00052445236,"about_ca_system_score_gemma":0.00035914534,"threshold_uncertainty_score":0.01655811},"labels":[],"label_agreement":null},{"id":"W3167623925","doi":"10.1177/24755303211024205","title":"Non-Medical Switching Impact on Patients and Providers – Psoriatic Disease Community Taking a Stand","year":2021,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Psoriatic arthritis; Psoriasis; Disease; Medicine; Medical insurance; Health insurance; Dermatology; Business; Internal medicine; Health care; Actuarial science; Political science","score_opus":0.11715052133032118,"score_gpt":0.38980245396608704,"score_spread":0.27265193263576587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167623925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723433,0.0015933915,0.000366086,0.0070695365,0.00019266353,0.0001192871,0.0041313963,0.000037895355,0.014146444],"genre_scores_gemma":[0.9947049,0.00026937135,0.00009000818,0.00049910904,0.000097386466,0.000018781966,0.0013604463,0.000005137192,0.0029547932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99640983,0.0012669262,0.00022026536,0.00037232132,0.00047799456,0.0012527794],"domain_scores_gemma":[0.98166305,0.0077666626,0.0045080823,0.00061130297,0.0008254778,0.0046254094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031539223,0.00033749148,0.0007285525,0.000880548,0.0012330532,0.0026967432,0.00069358863,0.0016099656,0.052627414],"category_scores_gemma":[0.019450195,0.00023387567,0.002261621,0.0011816798,0.0005843182,0.001308564,0.0016336761,0.0033215897,0.0013685933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076755024,0.0032488722,0.9194352,0.00016727501,0.0013500218,0.0004371014,0.00044201475,0.0023570298,0.0003781537,0.002815911,0.00527341,0.05641945],"study_design_scores_gemma":[0.00064585067,0.0017001318,0.9811447,0.00013641837,0.00094407593,0.0004707511,0.0025040563,0.0051872237,0.00026600974,0.003833126,0.0031231167,0.000044494904],"about_ca_topic_score_codex":0.036318,"about_ca_topic_score_gemma":0.036583934,"teacher_disagreement_score":0.052627414,"about_ca_system_score_codex":0.001918704,"about_ca_system_score_gemma":0.0029721614,"threshold_uncertainty_score":0.17605627},"labels":[],"label_agreement":null},{"id":"W4200186797","doi":"10.1177/24755303211062887","title":"Healthcare Providers Face Numerous Challenges in Treating Patients with Psoriasis: Results from a Mixed-Methods Study","year":2021,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Queen's University; Axdev Group (Canada)","funders":"Bristol-Myers Squibb","keywords":"Health care; Psoriasis; Face (sociological concept); Medicine; Dermatology; Nursing; Sociology; Political science","score_opus":0.023949479309775226,"score_gpt":0.2807003387961327,"score_spread":0.2567508594863575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200186797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99229455,0.001606448,0.0011666183,0.0015488092,0.000042819185,0.0010994968,0.00031204743,0.000006944207,0.0019224015],"genre_scores_gemma":[0.98943835,0.0023294303,0.0027364949,0.0026077162,0.00004253573,0.001939988,0.00022884688,0.00002202444,0.00065448874],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9612334,0.028366443,0.0029562993,0.0012910786,0.0034721151,0.0026807308],"domain_scores_gemma":[0.91754067,0.06180229,0.0060916543,0.0020224855,0.010570061,0.001972802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04729264,0.0004890822,0.0010068052,0.0021321499,0.005939442,0.005736762,0.0016243128,0.0015489846,0.0021428843],"category_scores_gemma":[0.07421923,0.0009133967,0.0008945134,0.0034780803,0.0027186302,0.0041813008,0.0047882,0.0018996574,0.00031753452],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017171426,0.00056492555,0.08195142,0.0010273597,0.000085391475,0.0005491609,0.8938853,0.000031701296,0.00023663123,0.00037499657,0.0009683216,0.02015301],"study_design_scores_gemma":[0.000033093038,0.00020390665,0.024480212,0.0008337095,0.00005884817,0.00028377483,0.9714239,0.000099760924,0.00010367571,0.0001309703,0.0023210822,0.000027084037],"about_ca_topic_score_codex":0.036494564,"about_ca_topic_score_gemma":0.08027438,"teacher_disagreement_score":0.04729264,"about_ca_system_score_codex":0.007595249,"about_ca_system_score_gemma":0.014593992,"threshold_uncertainty_score":0.25011033},"labels":[],"label_agreement":null},{"id":"W4200409644","doi":"10.1177/24755303211063841","title":"A Retrospective Study on the Effectiveness of Ixekizumab After Treatment With Secukinumab for Patients With Active Psoriatic Arthritis","year":2021,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Secukinumab; Ixekizumab; Psoriatic arthritis; Medicine; Dermatology; Arthritis; Psoriasis; Internal medicine","score_opus":0.008076299064382269,"score_gpt":0.2399081200722395,"score_spread":0.23183182100785724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200409644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986332,0.0006845243,0.000045976627,0.000025610478,0.000007553473,0.000010955141,0.00011891574,0.000001883293,0.00047137882],"genre_scores_gemma":[0.999608,0.0001268041,0.000024741368,0.000036502828,0.000015822052,0.0000056731906,0.00012792471,0.0000012730973,0.00005325951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861574,0.0003993803,0.00022274573,0.000294005,0.00029944486,0.00016875223],"domain_scores_gemma":[0.9959447,0.0009568168,0.0020720486,0.00019958374,0.00038515855,0.0004417271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009950796,0.0001804826,0.00043392114,0.00058570795,0.0004720879,0.00061841065,0.00021842004,0.00038155954,0.0013117003],"category_scores_gemma":[0.0032015457,0.00018720298,0.00054440234,0.0010018136,0.00032881458,0.0004634751,0.00022114464,0.00042585842,0.00022111746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003889409,0.0000585403,0.9970662,0.000018552148,0.00006104406,0.00032956927,0.0000778806,0.00001942121,0.00014260548,0.000009771224,0.00005609946,0.0017714254],"study_design_scores_gemma":[0.000045744495,0.0013712476,0.9946084,0.00001640197,0.0001123176,0.0026413472,0.0002820171,0.00010820872,0.0001383269,0.000014138935,0.0006541186,0.000007601524],"about_ca_topic_score_codex":0.0014242919,"about_ca_topic_score_gemma":0.0012369344,"teacher_disagreement_score":0.0014242919,"about_ca_system_score_codex":0.00035270432,"about_ca_system_score_gemma":0.00043272285,"threshold_uncertainty_score":0.0052625537},"labels":[],"label_agreement":null},{"id":"W4225380775","doi":"10.1177/24755303221099848","title":"Sex Differences in Moderate to Severe Psoriasis: Analysis of the Psoriasis Longitudinal Assessment and Registry","year":2022,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health","funders":"Janssen Scientific Affairs","keywords":"Psoriasis; Medicine; Longitudinal data; Dermatology; Demography","score_opus":0.021096602765689875,"score_gpt":0.25852365820692846,"score_spread":0.2374270554412386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225380775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981446,0.00013502923,0.00012938463,0.000046866488,0.0000054203333,0.0000120541945,0.0011438611,0.00000527966,0.0003773795],"genre_scores_gemma":[0.99875176,0.000050256218,0.00008199632,0.000021224652,0.00000716832,0.000015005732,0.0009793075,0.0000039241895,0.000089374465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982936,0.0006955188,0.00014059678,0.00034966663,0.00032879983,0.00019192867],"domain_scores_gemma":[0.9951616,0.0008906471,0.002591055,0.0004549336,0.00038522307,0.0005166181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027237493,0.00014890151,0.0003048428,0.0008537951,0.00032352994,0.0005786132,0.00029704007,0.0002324088,0.0013970055],"category_scores_gemma":[0.0048636263,0.00018656041,0.0005934821,0.00112721,0.00016221324,0.00045234972,0.00063466723,0.0004798938,0.00025626138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014867481,0.0000110536475,0.9990289,0.0000022790812,0.00003904939,0.000015469002,0.000026179994,0.00001296272,0.00003796046,0.000011550401,0.000090042886,0.00057588355],"study_design_scores_gemma":[0.000012056761,0.00007847127,0.9993393,0.0000028420043,0.00001974549,0.00010495631,0.000086143154,0.00014841085,0.000026815476,0.000012596948,0.00016607094,0.0000026287],"about_ca_topic_score_codex":0.0031026143,"about_ca_topic_score_gemma":0.0031161443,"teacher_disagreement_score":0.0031026143,"about_ca_system_score_codex":0.00019690602,"about_ca_system_score_gemma":0.00032037953,"threshold_uncertainty_score":0.014404774},"labels":[],"label_agreement":null},{"id":"W4229026528","doi":"10.1177/24755303221099292","title":"Practice Patterns of Palmoplantar Pustulosis: Patient Demographics and Treatment Options","year":2022,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Probity Medical Research; Queen's University; Trent University; SKiN Health","funders":"","keywords":"Palmoplantar pustulosis; Demographics; Medicine; Dermatology; Psoriasis","score_opus":0.012586717045956684,"score_gpt":0.229988582291355,"score_spread":0.2174018652453983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229026528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880078,0.0021508816,0.00025798986,0.002842679,0.00001442216,0.000051175783,0.0003692205,0.000014634183,0.0062913327],"genre_scores_gemma":[0.9983242,0.0007895883,0.00018263298,0.0003457187,0.000008444653,0.0000149744965,0.000097037555,0.000003685602,0.00023376184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990791,0.00020339248,0.00014721364,0.000115751805,0.000281357,0.00017317031],"domain_scores_gemma":[0.9968727,0.00057359977,0.0016526985,0.00005328978,0.0003710449,0.00047670398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055996975,0.00008771018,0.00019441325,0.00044590412,0.0006722776,0.00044153188,0.00025823677,0.0004045027,0.0033445882],"category_scores_gemma":[0.0034120898,0.0001050301,0.00014552403,0.00082066574,0.00036520005,0.00043271438,0.00036833255,0.0004323223,0.00029591113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027885988,0.000047805013,0.9883106,0.000048324495,0.000010455122,0.0010590386,0.0008134622,0.00005154959,0.00026910988,0.000099560784,0.0010717106,0.008190517],"study_design_scores_gemma":[0.000009655862,0.0001316718,0.97187185,0.00021982237,0.000014728838,0.016399601,0.0068898313,0.00042489968,0.00016689858,0.00021321322,0.0036401595,0.000017609158],"about_ca_topic_score_codex":0.014150012,"about_ca_topic_score_gemma":0.027935378,"teacher_disagreement_score":0.014150012,"about_ca_system_score_codex":0.0009494699,"about_ca_system_score_gemma":0.0015724158,"threshold_uncertainty_score":0.0281353},"labels":[],"label_agreement":null},{"id":"W4239805270","doi":"10.1177/2475530318812244","title":"2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis","year":2018,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Psoriatic arthritis; Guideline; Enthesitis; Internal medicine; Abatacept; Tofacitinib; Physical therapy; Intensive care medicine; Psoriasis; Disease; Dermatology; Rheumatoid arthritis; Rituximab; Pathology","score_opus":0.020224608349345873,"score_gpt":0.2757395728411959,"score_spread":0.25551496449185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239805270","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033925397,0.39901906,0.047036134,0.31779438,0.03169247,0.014890627,0.028764924,0.0017622417,0.15564767],"genre_scores_gemma":[0.03038685,0.45679367,0.2631426,0.11004468,0.010744714,0.020773383,0.065016866,0.00066115346,0.042436168],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9802096,0.0062128254,0.005500611,0.00072397315,0.006473076,0.00087997527],"domain_scores_gemma":[0.9714515,0.005480201,0.003897558,0.00053212966,0.017403333,0.0012352656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011294185,0.0016157365,0.002687653,0.007496189,0.0009784232,0.0034082553,0.004195967,0.005983225,0.008915457],"category_scores_gemma":[0.03350931,0.0009601356,0.0042868154,0.0054555763,0.0009164621,0.0020599724,0.0023493704,0.008670115,0.006332164],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093706185,0.00014971463,0.00090509915,0.00959167,0.00022405275,0.00031717672,0.00022226443,0.0006296555,0.0005067887,0.003850828,0.741376,0.24213299],"study_design_scores_gemma":[0.0005064206,0.0001285989,0.0050276797,0.046099685,0.000743219,0.001120022,0.00023414141,0.0008600427,0.00035214546,0.005028171,0.93982214,0.00007768708],"about_ca_topic_score_codex":0.018507307,"about_ca_topic_score_gemma":0.027809447,"teacher_disagreement_score":0.018507307,"about_ca_system_score_codex":0.0058369027,"about_ca_system_score_gemma":0.027064558,"threshold_uncertainty_score":0.059730053},"labels":[],"label_agreement":null},{"id":"W4328092607","doi":"10.1177/24755303231155118","title":"Development of Psoriasis Assessment Tools Among Patients in the CorEvitas Psoriasis Registry","year":2023,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Psoriasis; Medicine; Dermatology","score_opus":0.025627111057160066,"score_gpt":0.2648293605340589,"score_spread":0.23920224947689886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328092607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9516506,0.0010133546,0.019237256,0.001480635,0.000113683425,0.0030944324,0.014700937,0.0010038217,0.0077053923],"genre_scores_gemma":[0.94713295,0.00042499433,0.032894805,0.00035338596,0.0000836238,0.00369041,0.014785422,0.00009193295,0.0005424235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9869244,0.007868458,0.0015265947,0.0010680766,0.002056604,0.00055569207],"domain_scores_gemma":[0.96732837,0.016519675,0.0076307706,0.0028173095,0.004412554,0.0012912927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027602213,0.0006189541,0.0010640656,0.0032736,0.0004771122,0.0019398336,0.0017010116,0.00049923995,0.0017894572],"category_scores_gemma":[0.048927434,0.00049490057,0.0011654716,0.0025550628,0.0002546959,0.001759307,0.0018202135,0.0012790889,0.0009173571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044033278,0.00043126493,0.94199586,0.00011177347,0.00012946907,0.000074153744,0.00033930072,0.0011936314,0.00022941032,0.00026801764,0.0046585808,0.05012815],"study_design_scores_gemma":[0.00031414547,0.000953846,0.967849,0.00024572044,0.00016806433,0.00037410884,0.0008210244,0.020379959,0.0011274589,0.00081375655,0.006896133,0.000056702862],"about_ca_topic_score_codex":0.00330671,"about_ca_topic_score_gemma":0.0034415675,"teacher_disagreement_score":0.027602213,"about_ca_system_score_codex":0.00094193855,"about_ca_system_score_gemma":0.0021622572,"threshold_uncertainty_score":0.14597619},"labels":[],"label_agreement":null},{"id":"W4367183667","doi":"10.1177/24755303231173376","title":"Scarring Alopecia in Tumor Necrosis Factor-α Antagonists-Induced Scalp Psoriasis","year":2023,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Scalp; Medicine; Psoriasis; Dermatology; Tumor necrosis factor α; Scarring alopecia; Tumor necrosis factor alpha; Necrosis; Pathology; Internal medicine","score_opus":0.023177698944721745,"score_gpt":0.25614420054646037,"score_spread":0.23296650160173862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367183667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922963,0.0042748656,0.00088832073,0.0000622969,0.000016322101,0.00003202638,0.000044100365,0.000023662655,0.002362117],"genre_scores_gemma":[0.9989241,0.00069174333,0.00015724722,0.000026225372,0.00002791852,0.0000033360873,0.00002374241,0.000002200899,0.0001434494],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99976057,0.00006499642,0.000031804982,0.000036544385,0.000047828056,0.00005829593],"domain_scores_gemma":[0.99932194,0.00021767906,0.0002793429,0.000043593434,0.000059931834,0.0000774888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028661516,0.00026288442,0.0002631422,0.0006121478,0.0002473267,0.0003138345,0.00015264166,0.00029126284,0.0024087916],"category_scores_gemma":[0.0010808756,0.00012556528,0.0002254462,0.0004274171,0.00029282094,0.00020771845,0.00020735276,0.0003056,0.000378624],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011757668,0.0003092648,0.75871426,0.0005015547,0.00008885336,0.13600625,0.00085403136,0.0003299912,0.020159274,0.00028767454,0.00064588716,0.08092725],"study_design_scores_gemma":[0.000060668306,0.0010104583,0.40301406,0.000047285528,0.00006980688,0.58905303,0.0004225458,0.00044192412,0.003135148,0.00024240444,0.002491705,0.000010993979],"about_ca_topic_score_codex":0.0003632869,"about_ca_topic_score_gemma":0.00041322235,"teacher_disagreement_score":0.0024087916,"about_ca_system_score_codex":0.00014137132,"about_ca_system_score_gemma":0.00015800369,"threshold_uncertainty_score":0.00805825},"labels":[],"label_agreement":null},{"id":"W4385703089","doi":"10.1177/24755303231195967","title":"Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2021 Annual Meeting Proceedings","year":2023,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Women's College Hospital; University of Toronto; University Health Network","funders":"National Heart, Lung, and Blood Institute; Pfizer; National Psoriasis Foundation; University of Toronto; American Heart Association","keywords":"Psoriatic arthritis; Psoriasis; Medicine; Multidisciplinary approach; Session (web analytics); Disease; Family medicine; Psychological intervention; Health care; Nursing; Dermatology; Internal medicine; Political science","score_opus":0.012871185667864651,"score_gpt":0.2760214508283057,"score_spread":0.26315026516044104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385703089","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024296112,0.029133013,0.0041610682,0.25978228,0.20743123,0.0035937915,0.015505048,0.0007677536,0.45532978],"genre_scores_gemma":[0.066486925,0.022266136,0.007036876,0.033316158,0.071229674,0.0036356805,0.016694777,0.00046852813,0.7788652],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99844044,0.00041666758,0.00007723152,0.00013683863,0.0006050764,0.00032374926],"domain_scores_gemma":[0.99665713,0.00023691976,0.00016221877,0.0000587953,0.0011563898,0.001728597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004774617,0.000935396,0.00044218058,0.0008939766,0.0013550422,0.0028785316,0.00076330756,0.0021665064,0.07571003],"category_scores_gemma":[0.0034983484,0.00025545468,0.0004486683,0.00050798437,0.00026933325,0.0007225967,0.0017519281,0.0026094338,0.01851332],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015891147,0.000097777665,0.0005458382,0.000100303376,0.0000073330734,0.00007632884,0.00002885433,0.00004322078,0.0003285207,0.00042130463,0.96552503,0.03266647],"study_design_scores_gemma":[0.000088807,0.00010028527,0.004624201,0.00026185278,0.00000772686,0.000111520945,0.00012526292,0.00019009561,0.0002095032,0.00035172893,0.9939144,0.000014583206],"about_ca_topic_score_codex":0.0032978645,"about_ca_topic_score_gemma":0.009753005,"teacher_disagreement_score":0.07571003,"about_ca_system_score_codex":0.002516288,"about_ca_system_score_gemma":0.005572923,"threshold_uncertainty_score":0.25327528},"labels":[],"label_agreement":null},{"id":"W4410479885","doi":"10.1177/24755303251344134","title":"Combining Clinical, Genetic and Protein Markers Using Machine Learning Models Discriminates Psoriatic Arthritis Patients From Those With Psoriasis","year":2025,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Memorial University of Newfoundland","funders":"Krembil Foundation; Canada Foundation for Innovation; National Psoriasis Foundation","keywords":"Psoriatic arthritis; Medicine; Psoriasis; Single-nucleotide polymorphism; Biomarker; Internal medicine; Oncology; Arthritis; SNP; Immunology; Genotype; Gene; Biology; Genetics","score_opus":0.0286935721539253,"score_gpt":0.2850611823141742,"score_spread":0.2563676101602489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410479885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641392,0.001605405,0.030407215,0.00095102575,0.00007863897,0.00010986981,0.00073564856,0.00033493337,0.0016380213],"genre_scores_gemma":[0.99219716,0.00018695877,0.006621577,0.00011898191,0.00005376587,0.000028684157,0.0005737357,0.000009579972,0.00020958507],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99889815,0.0005312917,0.00010049674,0.00022379236,0.00013660167,0.00010971407],"domain_scores_gemma":[0.9956726,0.0031523055,0.0004664131,0.00015469884,0.00029182225,0.0002620967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025118052,0.0009577414,0.0012315097,0.0019566407,0.00030370505,0.0015320596,0.0004450667,0.00097544293,0.0009834892],"category_scores_gemma":[0.0063988566,0.00022988206,0.0011885694,0.00078324915,0.00026485175,0.00064998027,0.00043134915,0.0010063469,0.00057339715],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000874654,0.0004980609,0.89818794,0.000079983285,0.0005923445,0.00020826608,0.0000745303,0.03805777,0.0015241912,0.00017781049,0.0011761835,0.05854833],"study_design_scores_gemma":[0.00010318002,0.00085318094,0.23505932,0.000118108794,0.0005054563,0.0008615988,0.00016010596,0.7573756,0.0013553351,0.0026214316,0.000928591,0.000058135593],"about_ca_topic_score_codex":0.0020650455,"about_ca_topic_score_gemma":0.0027688055,"teacher_disagreement_score":0.0025118052,"about_ca_system_score_codex":0.00040549392,"about_ca_system_score_gemma":0.00058562116,"threshold_uncertainty_score":0.013283849},"labels":[],"label_agreement":null},{"id":"W4415531191","doi":"10.1177/24755303251382878","title":"Real-world Evidence of Brodalumab Safety for the Treatment of Psoriasis","year":2025,"lang":"en","type":"review","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health","keywords":"Pharmacovigilance; Psoriasis; Adverse effect; Safety profile; Incidence (geometry)","score_opus":0.04714031260971944,"score_gpt":0.32902946341031025,"score_spread":0.2818891508005908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415531191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20849425,0.72256154,0.005181767,0.01628624,0.0011430543,0.0009916922,0.009920981,0.00019850845,0.035222057],"genre_scores_gemma":[0.8774272,0.10070277,0.004338669,0.010191047,0.0013169686,0.00036782163,0.0046373964,0.00009839554,0.0009197246],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9570328,0.022321869,0.009112726,0.0030549855,0.0078070513,0.00067051745],"domain_scores_gemma":[0.7474686,0.16065723,0.060274668,0.0084831035,0.021326344,0.001790091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.043272614,0.00042448443,0.0014648024,0.0011289341,0.00043954724,0.0037447945,0.00114585,0.0019535553,0.0063770954],"category_scores_gemma":[0.10951104,0.00040219567,0.0032754757,0.0017411818,0.0013940007,0.0016102531,0.0007873507,0.0022004806,0.0009638499],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05319672,0.0012254525,0.13690622,0.096315496,0.032171413,0.0011681479,0.0018199818,0.0027345861,0.01130921,0.0052502602,0.030694246,0.6272083],"study_design_scores_gemma":[0.0141136935,0.03682164,0.4418805,0.06259197,0.045165658,0.011340065,0.0019697268,0.0033255294,0.015804991,0.008056498,0.35846642,0.00046324654],"about_ca_topic_score_codex":0.00061945274,"about_ca_topic_score_gemma":0.0011644097,"teacher_disagreement_score":0.043272614,"about_ca_system_score_codex":0.0012040049,"about_ca_system_score_gemma":0.0013364817,"threshold_uncertainty_score":0.22885019},"labels":[],"label_agreement":null}]}